Cocrystal Pharma Inc. to Present at Noble Capital Markets’ 16th Annual Investor Conference
February 11 2020 - 8:35AM
COCRYSTAL PHARMA, INC. (NASDAQ: COCP) (“Cocrystal” or the
“Company”), a clinical stage biotechnology company discovering and
developing novel antiviral therapeutics, today announced that
Dr. Gary Wilcox, Chairman and Chief Executive Officer of Cocrystal,
will present at NobleCon16 - Noble Capital Markets’ 16th Annual
Investor Conference on Tuesday, February 18, 2020 at 11:30 a.m. ET
in Hollywood, Florida.
In addition to the presentation, management will
also be available to participate in one-on-one meetings with
qualified members of the investor community who are registered to
attend the conference. To request a meeting, please contact the
NobleCon16 one-on-one desk. About Cocrystal Pharma,
Inc.
Cocrystal Pharma, Inc. is a clinical stage
biotechnology company discovering and developing novel antiviral
therapeutics that target the replication machinery of influenza
viruses, hepatitis C viruses, and noroviruses. Cocrystal employs
unique structure-based technologies and Nobel Prize winning
expertise to create first- and best-in-class antiviral drugs. For
further information about Cocrystal, please visit
www.cocrystalpharma.com.
Investor and Media Contact:JTC
Team, LLC(833) 475-8247COCP@jtcir.com
Cocrystal Pharma (NASDAQ:COCP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cocrystal Pharma (NASDAQ:COCP)
Historical Stock Chart
From Sep 2023 to Sep 2024